Dr. Miguel Reina-Campos is an Assistant Professor at the La Jolla Institute for Immunology in La Jolla, California. The Reina lab seeks to understand the underlying principles governing tissue immune networks that enable robust and long-term pr

#19: Lymphatics, stem cells, and postdocs with Dr. Shiri Gur-Cohen, Ph.D.

May 15th, 2023 1h 24m

Dr. Gur-Cohen is an Assistant Professor of Medicine in the Division of Regenerative Medicine at the University of California, San Diego. Dr. Gur-Cohen’s work has unearthed the lymphatic capillary network as a novel stem cell niche component, an

#18: Unconventional T cells with Dr. Mitchell Kronenberg, Ph.D.

Mar 24th, 2023 58m 7s

In this episode, Kellen speaks with Dr. Mitchell Kronenberg. Mitch is the chief scientific officer of the La Jolla Institute for Immunology, an adjunct professor at UC San Diego, and the co-director of a collaborative effort between the La Joll

#17: Gut microbiome therapeutics with Dr. Amir Zarrinpar, M.D. Ph.D.

Jan 27th, 2023 1h 30m

In this episode, Kellen speaks with Dr. Amir Zarrinpar. Amir is a board-certified gastroenterologist and an assistant professor at UC San Diego in the department of medicine. He completed his undergrad at Harvard, M.D. and Ph.D. at UCSD, and po

#16: Inflammatory bowel disease and proteomics with Dr. David Gonzalez, Ph.D.

Nov 10th, 2022 1h 27m

In this episode, Kellen speaks with Dr. David Gonzalez. David is an associate professor at UC San Diego in the pharmacology department of the school of medicine and the Skaggs school of pharmacy. He’s also the founder and director of the UCSD c

#15: Antimicrobial resistance with Dr. Victor Nizet, M.D.

Jun 19th, 2022 1h 8m

In this episode, Kellen interviews Dr. Victor Nizet, a distinguished professor of pediatrics and pharmaceutical sciences at UCSD and the vice chair of basic research in the department of pediatrics at UCSD. Kellen and Victor discuss one of the

#14: Fibrosis in CNS autoimmunity with Dr. Richard Daneman, Ph.D.

Apr 9th, 2022 49m 51s

In this episode, Kellen sits down for a conversation with Richard Daneman, an associate professor of neurosciences and pharmacology at UCSD. Kellen and Rich discuss the Daneman lab’s recent paper identifying a novel role of fibroblasts in the c

#13: Immune fibroblastic cells with Dr. Richard Gallo, M.D. Ph.D.

Feb 19th, 2022 30m 36s

In this episode, Kellen is joined by his thesis advisor Dr. Richard Gallo, a Distinguished Professor and the Founding Chairman of the Department of Dermatology at the University of California, San Diego. Kellen and Rich discuss two recent publi

#12: Omental fat, the “policeman of the abdomen”

Dec 29th, 2021 17m 5s

Omental adipose tissue has been considered an important component of host defense since at least 1906 when it was deemed “the policeman of the abdomen”. The precise mechanisms underlying omental host defense, however, remain elusive. Here, Kell

#11: Microbiome therapeutics with Dr. Alan O’Neill, Ph.D.

Nov 26th, 2021 44m 49s

This is a special episode of Inflammatory Content as it is our first episode with a guest! Dr. Alan O’Neill, Ph.D. joins Kellen to discuss his work on microbiome therapeutics—highlighting his recent report in eLife (link below)—as well as his o

#10: Cuts, commensals, and chemokines

Jun 28th, 2021 17m 49s

Getting physically injured is no fun—it can often take long periods of time to recover. What if we could accelerate the wound healing process? Here, Kellen dissects an original article, titled “The commensal skin microbiota triggers type I IFN-

#9: ILC2s and cancer

Jul 18th, 2020 13m 16s

Cutting-edge approaches to combat tumor development involve transplantation of anti-tumor T cells and natural killer cells. Natural killer (NK) cells belong to a greater family of innate lymphoid cells which includes the more recently describe

#8: Epigenome editing

May 25th, 2020 16m 26s

Fragile X syndrome is a genetic disorder and the leading cause of intellectual disability and autism. There is no treatment. In this episode, Kellen discusses recent gene therapy advances for treating Fragile X syndrome. The article highligh

#7: COVID19 PSA and unconventional T cells

Mar 26th, 2020 14m 44s

Medical systems around the world need our help with COVID19. After sharing an important PSA, Kellen dives into the topic of unconventional T cells. These novel immune subsets have unique functions with great therapeutic potential. In this ep

#6: Biofilm architecture

Mar 21st, 2020 14m 42s

Antibiotic resistance is an enormous public health problem. The prevalence of superbugs is increasing over time, whereas the number of drugs available to treat these microbes is not. Bacterial communities called biofilms harbor strains of bac

#5: Bacteria and immunotherapy

Feb 29th, 2020 14m 37s

Engineering bacteria to kill cancer cells… Sounds like science fiction, right? Well, it’s actually all science, no fiction! Sreyan Chowdhury and colleagues from Tal Danino’s lab at Columbia University describe this novel therapeutic approach

#4: ILC2s and neutrophils

Feb 2nd, 2020 26m 16s

In this episode, Kellen covers a topic near and dear to his heart – group two innate lymphoid cells, or ILC2s. Specifically, Kellen discusses the original article titled “Neutrophils restrain allergic airway inflammation by limiting ILC2 funct

#3: Commensal viruses

Jan 2nd, 2020 24m 50s

When most people think of viruses, they usually think of the negative aspect of viruses –- agents of infectious disease. We, however, are not most people! Not only are viruses useful biotechnological tools, but they are also capable of promot

#2: Plant medicine

Jan 1st, 2020 16m 37s

Plants are a great source of fiber and micronutrients, which makes them an important component of a heathy diet. However, it was recently shown that there is another aspect of plants that allows them to contribute to well-being –- exosomes. I

#1: Intro –- what this is and why I am doing it

Dec 27th, 2019 2m 53s

Brief introduction of what this podcast will entail and the reason behind its creation. To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo

Rate